Could a cheaper keytruda copy work just as well for melanoma?

NCT ID NCT06153238

Completed Disease control Sponsor: Sandoz Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study compares a new biosimilar drug (GME751) to the standard immunotherapy Keytruda in 322 adults with stage II or III melanoma that has been surgically removed. The goal is to see if the biosimilar stays in the body and works as well as Keytruda in preventing the cancer from coming back. Participants receive either drug as an infusion every few weeks, and researchers monitor drug levels, safety, and immune response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma metastatic melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA

Contacts and locations

Locations

Sandoz Investigational Site

Orange, California, 92868, United States
Sandoz Investigational Site

Clermont, Florida, 34711, United States
Sandoz Investigational Site

Orange City, Florida, 32763, United States
Sandoz Investigational Site

Banja Luka, Bosnia and Herzegovina
Sandoz Investigational Site

Mostar, Bosnia and Herzegovina
Sandoz Investigational Site

Sarajevo, Bosnia and Herzegovina
Sandoz Investigational Site

Tuzla, Bosnia and Herzegovina
Sandoz Investigational Site

Barretos, Brazil
Sandoz Investigational Site

Belo Horizonte, Brazil
Sandoz Investigational Site

Canoas, Brazil
Sandoz Investigational Site

Caxias do Sul, Brazil
Sandoz Investigational Site

Curitiba, Brazil
Sandoz Investigational Site

Florianópolis, Brazil
Sandoz Investigational Site

Fortaleza, Brazil
Sandoz Investigational Site

Itajaí, Brazil
Sandoz Investigational Site

Porto Alegre, Brazil
Sandoz Investigational Site

Porto Velho, Brazil
Sandoz Investigational Site

Salvador, Brazil
Sandoz Investigational Site

São José do Rio Preto, Brazil
Sandoz Investigational Site

Besançon, France
Sandoz Investigational Site

Nantes, France
Sandoz Investigational Site

Batumi, Georgia
Sandoz Investigational Site

Tbilisi, Georgia
Sandoz Investigational Site

Mainz, Germany
Sandoz Investigational Site

Münster, Germany
Sandoz Investigational Site

Tübingen, Germany
Sandoz Investigational Site

Catanzaro, Italy
Sandoz Investigational Site

Rozzano, Italy
Sandoz Investigational Site

Klaipėda, Lithuania
Sandoz Investigational Site

Vilnius, Lithuania
Sandoz Investigational Site

George Town, Malaysia
Sandoz Investigational Site

Johor Bahru, Malaysia
Sandoz Investigational Site

Kuala Lumpur, Malaysia
Sandoz Investigational Site

Kuching, Malaysia
Sandoz Investigational Site

Malacca, Malaysia
Sandoz Investigational Site

Putrajaya, Malaysia
Sandoz Investigational Site

Mexico City, Mexico
Sandoz Investigational Site

Oaxaca City, Mexico
Sandoz Investigational Site

San Luis Potosí City, Mexico
Sandoz Investigational Site

Veracruz, Mexico
Sandoz Investigational Site

Chisinau, Moldova
Sandoz Investigational Site

Skopje, North Macedonia
Sandoz Investigational Site

Bacolod, Philippines
Sandoz Investigational Site

Bucharest, Romania
Sandoz Investigational Site

Cluj-Napoca, Romania
Sandoz Investigational Site

Belgrade, Serbia
Sandoz Investigational Site

Kamenitz, Serbia
Sandoz Investigational Site

Niš, Serbia
Sandoz Investigational Site

Johannesburg, South Africa
Sandoz Investigational Site

Phoenix, South Africa
Sandoz Investigational Site

Badalona, Spain
Sandoz Investigational Site

Barcelona, Spain
Sandoz Investigational Site

Cáceres, Spain
Sandoz Investigational Site

Madrid, Spain
Sandoz Investigational Site

Murcia, Spain
Sandoz Investigational Site

Santiago de Compostela, Spain
Sandoz Investigational Site

Seville, Spain
Sandoz Investigational Site

Valencia, Spain
Sandoz Investigational Site

Zaragoza, Spain
Sandoz Investigational Site

Ankara, Turkey (Türkiye)
Sandoz Investigational Site

Yüreğir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.